Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7375 p602
12 November 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Post-operative vomiting

Post-operative vomiting is more effectively reduced by a new class of drugs, called NK-1 receptor antagonists, than by ondansetron, according to a phase III trial presented at the American Society of Anesthesiologists meeting in Atlanta last month. Vomiting was not experienced by 95 per cent of patients in the NK-1 group and 74 per cent in the ondansetron group; there was no difference between the two in reducing nausea.

Back to Top


©The Pharmaceutical Journal